3-[4-[3-tert-butyl-5-[4-(4-tert-butylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-(4-phenylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-[4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;platinum

C143H128N9O3Pt3-3 — CID 163652210

IUPAC3-[4-[3-tert-butyl-5-[4-(4-tert-butylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-(4-phenylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-[4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;platinum
SMILESCC(C)(C)c1cc(-c2cc(-c3ccc(-c4ccccc4)cc3)ccn2)[c-]c(-c2cccc3c2nc(-c2cc4c(cc2O)CCCC4)n3-c2ccccc2)c1.CC(C)(C)c1ccc(-c2ccnc(-c3[c-]c(-c4cccc5c4nc(-c4cc6c(cc4O)CCCC6)n5-c4ccccc4)cc(C(C)(C)C)c3)c2)cc1.[2H]C([2H])([2H])c1ccc(-c2ccnc(-c3[c-]c(-c4cccc5c4nc(-c4cc6c(cc4O)CCCC6)n5-c4ccccc4)cc(C(C)(C)C)c3)c2)cc1.[Pt].[Pt].[Pt]
InChIInChI=1S/C50H42N3O.C48H46N3O.C45H40N3O.3Pt/c1-50(2,3)41-28-39(27-40(29-41)45-31-38(25-26-51-45)35-23-21-34(22-24-35)33-13-6-4-7-14-33)43-19-12-20-46-48(43)52-49(53(46)42-17-8-5-9-18-42)44-30-36-15-10-11-16-37(36)32-47(44)54;1-47(2,3)37-21-19-31(20-22-37)34-23-24-49-42(29-34)36-25-35(26-38(27-36)48(4,5)6)40-17-12-18-43-45(40)50-46(51(43)39-15-8-7-9-16-39)41-28-32-13-10-11-14-33(32)30-44(41)52;1-29-17-19-30(20-18-29)33-21-22-46-40(27-33)35-23-34(24-36(25-35)45(2,3)4)38-15-10-16-41-43(38)47-44(48(41)37-13-6-5-7-14-37)39-26-31-11-8-9-12-32(31)28-42(39)49;;;/h4-9,12-14,17-26,28-32,54H,10-11,15-16H2,1-3H3;7-9,12,15-24,26-30,52H,10-11,13-14H2,1-6H3;5-7,10,13-22,24-28,49H,8-9,11-12H2,1-4H3;;;/q3*-1;;;/i;;1D3;;;
InChIKeyNGMFLVRETUXXII-IDGSXTKZSA-N
MW2608.91 g/mol
LogP35.58
Rot. Bonds17

About 3-[4-[3-tert-butyl-5-[4-(4-tert-butylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-(4-phenylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-[4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;platinum

3-[4-[3-tert-butyl-5-[4-(4-tert-butylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-(4-phenylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-[4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;platinum (PubChem CID 163652210) has the molecular formula C143H128N9O3Pt3-3 and a molecular weight of 2608.91 g/mol. Its IUPAC name is 3-[4-[3-tert-butyl-5-[4-(4-tert-butylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-(4-phenylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-[4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;platinum.

Molecular Properties

Compound Name3-[4-[3-tert-butyl-5-[4-(4-tert-butylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-(4-phenylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-[4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;platinum
PubChem CID163652210
Molecular FormulaC143H128N9O3Pt3-3
Molecular Weight2608.91 g/mol
Exact Mass2606.93
IUPAC Name3-[4-[3-tert-butyl-5-[4-(4-tert-butylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-(4-phenylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-[4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;platinum
SMILESCC(C)(C)c1cc(-c2cc(-c3ccc(-c4ccccc4)cc3)ccn2)[c-]c(-c2cccc3c2nc(-c2cc4c(cc2O)CCCC4)n3-c2ccccc2)c1.CC(C)(C)c1ccc(-c2ccnc(-c3[c-]c(-c4cccc5c4nc(-c4cc6c(cc4O)CCCC6)n5-c4ccccc4)cc(C(C)(C)C)c3)c2)cc1.[2H]C([2H])([2H])c1ccc(-c2ccnc(-c3[c-]c(-c4cccc5c4nc(-c4cc6c(cc4O)CCCC6)n5-c4ccccc4)cc(C(C)(C)C)c3)c2)cc1.[Pt].[Pt].[Pt]
InChIInChI=1S/C50H42N3O.C48H46N3O.C45H40N3O.3Pt/c1-50(2,3)41-28-39(27-40(29-41)45-31-38(25-26-51-45)35-23-21-34(22-24-35)33-13-6-4-7-14-33)43-19-12-20-46-48(43)52-49(53(46)42-17-8-5-9-18-42)44-30-36-15-10-11-16-37(36)32-47(44)54;1-47(2,3)37-21-19-31(20-22-37)34-23-24-49-42(29-34)36-25-35(26-38(27-36)48(4,5)6)40-17-12-18-43-45(40)50-46(51(43)39-15-8-7-9-16-39)41-28-32-13-10-11-14-33(32)30-44(41)52;1-29-17-19-30(20-18-29)33-21-22-46-40(27-33)35-23-34(24-36(25-35)45(2,3)4)38-15-10-16-41-43(38)47-44(48(41)37-13-6-5-7-14-37)39-26-31-11-8-9-12-32(31)28-42(39)49;;;/h4-9,12-14,17-26,28-32,54H,10-11,15-16H2,1-3H3;7-9,12,15-24,26-30,52H,10-11,13-14H2,1-6H3;5-7,10,13-22,24-28,49H,8-9,11-12H2,1-4H3;;;/q3*-1;;;/i;;1D3;;;
InChIKeyNGMFLVRETUXXII-IDGSXTKZSA-N
XLogP35.58
TPSA152.82 Ų
H-Bond Donors3
H-Bond Acceptors12
Rotatable Bonds17
Heavy Atoms158
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002608.91
LogP ≤ 535.58
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 3-[4-[3-tert-butyl-5-[4-(4-tert-butylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-(4-phenylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-[4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[4-[3-tert-butyl-5-[4-(4-tert-butylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-(4-phenylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-[4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;platinum?
The IUPAC name of 3-[4-[3-tert-butyl-5-[4-(4-tert-butylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-(4-phenylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-[4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;platinum (CID 163652210) is 3-[4-[3-tert-butyl-5-[4-(4-tert-butylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-(4-phenylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-[4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;platinum.
What is the SMILES notation for 3-[4-[3-tert-butyl-5-[4-(4-tert-butylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-(4-phenylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-[4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;platinum?
The canonical SMILES for 3-[4-[3-tert-butyl-5-[4-(4-tert-butylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-(4-phenylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-[4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;platinum is CC(C)(C)c1cc(-c2cc(-c3ccc(-c4ccccc4)cc3)ccn2)[c-]c(-c2cccc3c2nc(-c2cc4c(cc2O)CCCC4)n3-c2ccccc2)c1.CC(C)(C)c1ccc(-c2ccnc(-c3[c-]c(-c4cccc5c4nc(-c4cc6c(cc4O)CCCC6)n5-c4ccccc4)cc(C(C)(C)C)c3)c2)cc1.[2H]C([2H])([2H])c1ccc(-c2ccnc(-c3[c-]c(-c4cccc5c4nc(-c4cc6c(cc4O)CCCC6)n5-c4ccccc4)cc(C(C)(C)C)c3)c2)cc1.[Pt].[Pt].[Pt].
What is the InChIKey of 3-[4-[3-tert-butyl-5-[4-(4-tert-butylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-(4-phenylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-[4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;platinum?
The InChIKey is NGMFLVRETUXXII-IDGSXTKZSA-N. The full InChI is InChI=1S/C50H42N3O.C48H46N3O.C45H40N3O.3Pt/c1-50(2,3)41-28-39(27-40(29-41)45-31-38(25-26-51-45)35-23-21-34(22-24-35)33-13-6-4-7-14-33)43-19-12-20-46-48(43)52-49(53(46)42-17-8-5-9-18-42)44-30-36-15-10-11-16-37(36)32-47(44)54;1-47(2,3)37-21-19-31(20-22-37)34-23-24-49-42(29-34)36-25-35(26-38(27-36)48(4,5)6)40-17-12-18-43-45(40)50-46(51(43)39-15-8-7-9-16-39)41-28-32-13-10-11-14-33(32)30-44(41)52;1-29-17-19-30(20-18-29)33-21-22-46-40(27-33)35-23-34(24-36(25-35)45(2,3)4)38-15-10-16-41-43(38)47-44(48(41)37-13-6-5-7-14-37)39-26-31-11-8-9-12-32(31)28-42(39)49;;;/h4-9,12-14,17-26,28-32,54H,10-11,15-16H2,1-3H3;7-9,12,15-24,26-30,52H,10-11,13-14H2,1-6H3;5-7,10,13-22,24-28,49H,8-9,11-12H2,1-4H3;;;/q3*-1;;;/i;;1D3;;;.
What are the key properties of 3-[4-[3-tert-butyl-5-[4-(4-tert-butylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-(4-phenylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-[4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;platinum?
3-[4-[3-tert-butyl-5-[4-(4-tert-butylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-(4-phenylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-[4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;platinum has a molecular weight of 2608.91 g/mol, XLogP of 35.58, 17 rotatable bonds, 3 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[4-[3-tert-butyl-5-[4-(4-tert-butylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-(4-phenylphenyl)-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;3-[4-[3-tert-butyl-5-[4-[4-(trideuteriomethyl)phenyl]-2-pyridinyl]benzene-6-id-1-yl]-1-phenylbenzimidazol-2-yl]-5,6,7,8-tetrahydronaphthalen-2-ol;platinum is sourced from PubChem (CID 163652210), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).